FDA Adds Kantaro’s Semi-Quantitative COVID-19 Antibody Test to Revised Emergency Use Authorization for Convalescent Plasma
COVID-SeroKlir is a high-performance test that detects the presence and precise level of SARS-CoV-2 IgG antibodies NEW YORK, Feb. 10, 2021 — Kantaro Biosciences, LLC, a joint venture between the Mount Sinai Health System and RenalytixAI (LSE:RENX /NASDAQ: RNLX), and manufacturing partner …
Kantaro and Atrys Health Partnership Expand Global Footprint of Quantitative COVID-19 Antibody Tests in Europe and South America
Kantaro’s COVID-SeroKlir and COVID-SeroIndex are high-performing tests that detect the presence and precise level of neutralizing antibodies¹ First and only quantitative COVID-19 antibody tests that do not require proprietary equipment NEW YORK, Feb. 8, 2021 — Kantaro Biosciences, LLC, a joint venture …
Robert J. Desnick , MD, E. Premkumar Reddy, PhD, and Edward Schuchman, PhD, Elected to the National Academy of Inventors
Mount Sinai researchers Robert J. Desnick, MD, PhD, E. Premkumar (Prem) Reddy, PhD, and Edward Schuchman, PhD, became Fellows of the National Academy of Inventors (NAI). The National Academy of Inventors (NAI) is a prestigious organization, comprised of international universities, and governmental …
MSIP Honors Inventors for their Exemplary Work in Developing Mount Sinai’s COVID-19 Antibody Test
At the Innovation Awards Ceremony on December 8, Mount Sinai Innovation Partners (MSIP) presented the award for Inventor of the Year to eight individuals whose efforts led to the development of multiple diagnostic tests for the detection of antibodies against the COVID-19 …
Next-gen antibody tests promise more answers to Covid-19 questions
MedCity News The new tests can open a window into the duration of immunity and to the antibody levels needed to sustain it. But first, a universal standard is needed to ensure results are comparable between tests. The next generation of antibody …
FDA clears a ‘new generation’ of Covid antibody test designed to tell how well someone is protected against the virus
CNBC — Wednesday, November 25, 2020 The FDA on Wednesday authorized one of the first Covid-19 tests that measures the amount of neutralizing antibodies produced by the body’s immune system after exposure to the virus — a “new generation” of coronavirus test that …
Kantaro Receives FDA Emergency Use Authorization for Semi-Quantitative COVID-19 Antibody Test Kit that Detects the Presence and Level of SARS-CoV-2 IgG Antibodies
COVID-SeroKlir is a high-performance semi-quantitative antibody test kit based on Mount Sinai technology, with a broad range of applications in the fight against COVID-19 The Kantaro test is being manufactured at scale and immediately available in the U.S. NEW YORK, Nov. 25, 2020 /PRNewswire/ …
Mount Sinai Researchers Streamline Patient Data to Find Patterns in COVID-19 Patients
With the influx of patient data resulting from the SARS-CoV-2 pandemic, the Mount Sinai COVID Informatics Center is collaborating with London-based software company Clinithink to uncover key findings that can enable better treatment methods for COVID-19 patients. Clinithink’s artificial intelligence platform, CLiX, …
Live Interview: Trellus Health Co-Founders Marla Dubinsky, MD and Laurie Keefer, PhD
Tune in to The Innovation Cafe, MSIP’s LinkedIn Live interview series, where Marla Dubinsky, MD and Laurie Keefer, PhD, of the Susan and Leonard Feinstein Inflammatory Bowel Disease (IBD) Clinical Center at Mount Sinai discussed how they developed Trellus Health – the …
Trellus Health Secures $5M Seed Funding to Transform Care for Chronic Conditions
Collaborates with Mount Sinai to deliver resilience-driven, connected care, integrating expert clinical and behavioral health for better outcomes Trellus Health, a resilience-driven digital health solution for chronic conditions, today announced that it has raised $5 million of seed funding to transform the way chronic …